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Abstract The in situ immunocytochemical properties of
olfactory ensheathing cells (OECs) have been well studied
in several small to medium sized animal models including
rats, mice, guinea pigs, cats and canines. However, we
know very little about the antigenic characteristics of OECs
in situ within the adult and developing human olfactory
bulb and nerve roots. To address this gap in knowledge we
undertook an immunocytochemical analysis of the 11–19
pcw human foetal olfactory system. Human foetal OECs
in situ possessed important differences compared to rodents
in the expression of key surface markers. P75NTR was not
observed in OECs but was strongly expressed by human
foetal Schwann cells and perineurial olfactory nerve
fibroblasts surrounding OECs. We define OECs throughout
the 11–19 pcw human olfactory system as S100/vimentin/
SOX10? with low expression of GFAP. Our results sug-
gest that P75NTR is a robust marker that could be utilised
with cell sorting techniques to generate enriched OEC
cultures by first removing P75NTR expressing Schwann
cells and fibroblasts, and subsequently to isolate OECs
after P75NTR upregulation in vitro. O4 and PSA-NCAM
were not found to be suitable surface antigens for OEC
purification owing to their ambiguous and heterogeneous
expression. Our results highlight the importance of cor-
roborating cell markers when translating cell therapies
from animal models to the clinic.
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Abbreviations
EPL External plexiform layer
GFAP Glial fibrillary acid protein
GL Glomeruli layer
IPL Internal plexiform layer
MCL Mitral cell layer
NCAM Neural cell adhesion molecule
NPY Neuropeptide Y
OB Olfactory bulb
OEC Olfactory ensheathing cell
ONF Olfactory nerve fibroblast
ON Olfactory nerve
ONL Olfactory nerve layer
ORNs Olfactory receptor neurons
P75NTR Low affinity neurotrophin receptor
Pcw Post conception weeks
PSA-NCAM Polysialylated neural cell adhesion
molecule
Introduction
For over two decades researchers have been studying the
therapeutic potential of olfactory ensheathing cells (OECs)
to treat traumatic injuries to the central nervous system
(Barnett and Riddell 2007; Mackay-Sim and St John 2011;
Raisman et al. 2012; Gladwin and Choi 2015). OECs are
unique glial cells that exist exclusively within the olfactory
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system and perform a vital role in supporting the continual
turnover of short-lived olfactory receptor neurons (ORNs)
throughout adult life (Doucette 1993). New ORNs must
accurately extend their axons from their origin in the
olfactory epithelium, along the peripheral olfactory nerves,
and into the central nervous system where they must form
appropriate connections within the olfactory nerve layer of
the olfactory bulb. The olfactory system is the only loca-
tion in humans where such axon growth and path-finding
occurs continuously across the peripheral-central nervous
system boundary throughout life (Doucette 1991). The
ensheathment of ORN axons by processes of OECs along
the entire olfactory pathway is vital for this to occur. OECs
are dynamic and versatile glia uniquely possessing char-
acteristics of both peripheral Schwann cells and central
nervous system astrocytes. These properties enable OECs
to maintain both the functioning of mature ORNs and
promote and support new ORN growth in both the
peripheral and central nervous system.
With this exceptional combination of properties, OECs
are prime candidates for therapeutic transplants to promote
CNS regeneration. To date, hundreds of studies in experi-
mental nervous system injury models and recent studies in
humans have provided convincing evidence to support the
clinical development of OEC transplantation (Mackay-Sim
et al. 2008; Granger et al. 2012; Tabakow et al. 2014;
Watzlawick et al. 2016). These studies have shown OECs
can provide a wide range of therapeutic effects. OEC
transplants have been reported to enhance tissue preser-
vation and promote functional recovery by; reducing
inflammation and lesion cavitation; promoting neuronal
survival and plasticity; promoting angiogenesis; enhancing
remyelination of spared axons, and promoting regeneration
of damaged axonal pathways by bridging the lesion with a
growth-permissive substrate (Keyvan-Fouladi et al. 2003;
Lakatos et al. 2003; Khankan et al. 2016). A recent meta-
analysis of 62 experimental studies in rodent models of SCI
concluded that OEC transplants enhanced functional
recovery with an effect size of 19.2 % (after adjusting for
publication bias and missing data) measured using the
Basso, Beattie, and Bresnahan locomotor scoring method
(Watzlawick et al. 2016).
In experimental transplantation studies OECs are most
often obtained from the olfactory nerve layer (ONL) of the
olfactory bulb (OB), and less commonly from the olfactory
mucosa. OECs can be isolated from adult or embry-
onic/foetal tissue and expanded to a limited degree in
culture. Commonly, OEC transplants contain a mixture of
cells depending on the tissue source, however despite the
potential complexity of the cell mixture, often only details
of the OEC and olfactory fibroblast components are
described in published papers. The majority of our
knowledge of OEC biology and reparative properties has
arisen from rodent studies. In particular, the immunocyto-
chemical characteristics of OECs have been well studied in
rats and mice with the general consensus that OECs
express the low affinity neurotrophin receptor P75NTR,
S100 and GFAP in situ and in vitro (Gong et al. 1994;
Franceschini and Barnett 1996; Au et al. 2002). These three
antigens are the most commonly used markers to identify
OECs in therapeutic cultures (Kawaja et al. 2009).
To improve culture yields, rodent OECs can be purified
from mixed cell cultures or enriched using various meth-
ods, most commonly by cell sorting using the expression of
P75NTR. This can be performed on the initial cell suspen-
sion obtained after tissue digestion, or after plating and
culturing for several days (Kawaja et al. 2009). One
drawback to this method is that contaminating Schwann
cells present in peripheral nerve bundles in the mucosa and
surrounding arterioles in the ONL also express P75NTR and
so, may be co-isolated along with OECs. Due to similari-
ties in their antigenic characteristics, currently there are no
established protocols for purifying rodent OECs from
Schwann cells. Studies in larger animal models have
revealed inter-species differences in the antigenic charac-
teristics of OECs in situ (Wewetzer et al. 2011). In a canine
model, P75NTR was expressed in non-myelinating Schwann
cells and in connective tissue surrounding olfactory nerves
in situ, but not in OECs (Bock et al. 2007). As canine
OECs only upregulate P75NTR after a period of time in
culture, Schwann cells can be removed from the initial cell
digest using P75NTR immunopanning (Ziege et al. 2013).
The resulting suspension can be cultured to allow time for
OECs to upregulate P75NTR and then subjected to a second
round of immunopanning to isolate OECs from any
remaining contaminating cells. These studies highlight the
importance of corroborating OEC markers when extrapo-
lating protocols developed in rodent models to other spe-
cies. A lack of P75NTR expression in OECs in situ was also
reported in cats and guinea pig (Smithson and Kawaja
2009). Immunocytochemical characterisation in situ not
only provides markers for purification and identification of
OECs, but also provides insights into their complex biol-
ogy. Studies in rodents have demonstrated OECs differ-
entially express several antigens in the olfactory bulb and
mucosa, and between the inner and outer layers of the
olfactory bulb (Vincent et al. 2005). OECs in the olfactory
nerves and outer ONL express P75NTR, whilst OECs in the
inner ONL do not express P75NTR but do express neu-
ropeptide Y and GFAP (Franceschini and Barnett 1996; Au
et al. 2002). These data suggest functional differences may
exist between anatomical OEC populations. Indeed, studies
have shown OECs from different regions of the ONL and
olfactory nerve differ in their phagocytic capabilities,
migratory and cell–cell interactive behaviours (Lohr et al.
2014; Ekberg and St John 2015). These differential
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properties could be exploited to enhance the efficacy of
therapeutic transplants.
The immunocytochemical characterisation of human
OECs in situ has generally been limited to the analysis
of biopsies of the adult human olfactory mucosa; very
little is known about the antigenic characteristics of
adult and developing human OECs within the olfactory
bulb and nerve roots. The small number of studies that
have described human OECs in situ in the adult olfac-
tory mucosa have presented conflicting results with some
suggesting OECs do express P75NTR (Bianco et al. 2004;
Kachramanoglou et al. 2013; Winstead et al. 2014),
whilst Holbrook et al. (2016) suggest that similar to
canines, olfactory perineurial cells express P75NTR, but
OECs do not (Holbrook et al. 2016). Validation of
P75NTR expression or lack thereof in human OECs
in situ is necessary for developing protocols for correctly
identifying and enriching OECs in cultures for future
clinical trials.
For clinical application, autologous OEC transplants
would be ideal however, obtaining OECs from the
olfactory nerve layer of a patient requires an invasive
and risky brain operation resulting in the unilateral loss
of an entire olfactory bulb and risks of anosmia,
meningitis, stroke or death. Biopsies of olfactory mucosa
are a safer alternative but isolating OECs from these
biopsies can be difficult and yields can be variable,
especially where a patient may possess a pre-existing
nasal disease (Kachramanoglou et al. 2013). Alterna-
tively, in the future OECs may be generated from patient
stem cells such as hair follicle neural crest stem cells or
from induced pluripotent stem cells. However, despite
some recent progress, our knowledge of the pathways
that control OEC development from the neural crest, and
how these pathways differ from Schwann cell develop-
ment are limited (Barraud et al. 2010; Miller et al.
2016). Thus, additional allogeneic sources of OECs may
be required until appropriate differentiation protocols to
generate OECs from patient stem cells have been
developed and validated.
Despite ethical considerations, discarded human foe-
tuses could provide an additional source of human olfac-
tory tissue for research purposes and a supplemental cell
source during the initial clinical development of OEC
therapies. Transplants of human foetal cells have been used
historically to provide proof-of-concept for various regen-
erative cell therapies such as photoreceptor replacement
therapy (Humayun et al. 2000). Foetal OECs could be used
clinically where it is either not possible to obtain patient
autologous OECs due to pre-existing pathologies or where
patient autologous OEC cultures are not of sufficient yield
or quality. Proof-of-concept studies demonstrating the
feasibility of allogeneic OEC grafts with short-term
immunosuppression in animal models of spinal cord injury
have already shown some promising results including axon
regeneration and recovery of directed forepaw reaching (Li
et al. 2016).
To address the knowledge gap regarding the character-
istics of human OECs in situ and to corroborate expression
of rodent OEC markers in human foetal OECs, we under-
took an immunocytochemical analysis of the 11–19 pcw
human foetal olfactory system.
Materials and methods
This project is covered by the Human Developmental
Biology Resource (HDBR) HTA tissue bank licence and
ethical approval. Details of approval terms can be found
at www.hdbr.org. The human foetal material was pro-
vided by the joint MRC (Grant #G0700089)/Wellcome
Trust (Grant # GR082557) Human Developmental
Biology Resource (www.hdbr.org). Olfactory tissue
blocks from aborted human foetuses (Table 1) were
obtained with maternal consent and fixed in 4 %
paraformaldehyde overnight. Samples 1–5 were dehy-
drated, paraffin embedded and sectioned by microtome.
Tissue sections were deparaffinised in histoclear, rehy-
drated in graded alcohol and antigen retrieval was per-
formed (60 min in 90 C Tris/EDTA with 0.05 % Tween
pH9). Samples 6–10 were cryoprotected in sucrose,
frozen in OCT in a slurry of isopentane and dry ice and
then cryosectioned.
All tissue sections were blocked in antibody diluent
(2 % milk, 1 % BSA and 0.1 % triton X-100) for 1 h at
room temperature prior to incubating in primary antibodies
(Table 2) overnight at 4 C. Sections were then washed
and incubated with the appropriate secondary antibodies
(Invitrogen Alexafluor series; goat anti-chicken 546; goat
Table 1 Details of the human foetal samples and tissue processing
methods
Sample Age (pcw) Method
1 11 Paraffin
2 12 Paraffin
3 12 Paraffin
4 14 Paraffin
5 17 Paraffin
6 12 Cryosection
7 12 Cryosection
8 12 Cryosection
9 17 Cryosection
10 19 (no bulbs) Cryosection
pcw post conception weeks
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anti-rabbit 488; donkey anti-mouse 488; donkey anti-rabbit
546, donkey anti-goat 633; goat anti-mouse IgM 488;
DAPI) at 1:500 dilution at room temperature in blocking
buffer for 2 h. Immunolabelling by all antibodies was
compared to positive controls consisting of adjacent areas
of the foetal brain, face, optic and oculomotor nerves, and
negative controls where the primary antibody was omitted
or replaced with an isotype control. Adjacent sections were
stained with hematoxylin and eosin. Immunofluorescent
micrographs were generated using either a Leica TCS SP
confocal microscope (963 or 940 objective) or for large
area montages with a Zeiss AxioScan Z.1 slide scanner
(920 objective).
Results
The structure and cellular morphology of the olfactory
system in our foetal samples were well preserved by our
tissue processing methods. The OB, olfactory nerves and
mucosa were easily distinguished in tissue sections at all
foetal ages (11–19 pcw) as shown by H&E (Supplemental
Fig. 1). The ONL was observed at all ages as a thin highly
cellular layer covering the surface of the OB that became
thicker in depth towards the rostral and inferior surfaces. In
agreement with the literature we observed poor lamination
in the OB at 11 & 12 pcw, by 14 pcw lamination became
more evident and was clearly observed at 17 pcw (Hum-
phrey 1940; Chuah and Zheng 1992; Mu¨ller and O’Rahilly
2004). At 17 pcw glomeruli were observed but appeared
poorly developed similar to that described by Chuah and
Zheng (1987).
Immunocytochemistry
Immunolocalization of TUJ, S100, and SOX10
TUJ-1 and TUJ-20 antibodies detect beta III tubulin, a
specific form of tubulin found in the microtubules of
neurons. Both TUJ antibodies intensely labelled OSNs in
the human foetal samples. At all developmental ages
studied, SOX10? nuclei and intense TUJ and S100
immunoreactivity was observed along the entirety of the
olfactory nerves (ONs) and throughout the ONL (Fig. 1a–b
and Supplemental Fig. 2a). The ONL surrounding the OB
could be clearly identified by intense TUJ, S100 and
SOX10 labelling. Double immunolabelling confirmed that
S100? cells were tightly associated with olfactory axons.
Confocal micrographs of transverse sections of ONs clearly
Table 2 Details of the primary antibodies
Primary antibody Manufacturer details Host, dilution factor Number of tissue
sections labelled
TUJ-1 Covance, MMS-435P-250 Mouse monoclonal IgG, 1/500 56
S100 Dako, Z0311 Rabbit polyclonal IgG, 1/750 117
SOX10 Santa cruz, SC-17342 Goat polyclonal IgG, 1/50 112
GAP-43 Millipore, AB5220 Rabbit polyclonal IgG, 1/250 30
Nestin Abcam, ab22035 Mouse monoclonal IgG, 1/100 14
GFAP Millipore, MAB360 Mouse monoclonal IgG, 1/500 14
GFAP Dako, Z0334 Rabbit polyclonal IgG, 1/500 51
Vimentin Millipore, AB5733 Chicken Polyclonal IgG, 1/250 28
P75 Sigma, N5408 Mouse monoclonal IgG, 1/250 42
O4 Sigma, O7139 Mouse monoclonal IgM, 1/100 28
PSA-NCAM Millipore, MAB5324 Mouse monoclonal clone 2-2B IgM, 1/200 28
NCAM Abcam, AB5032 Rabbit polyclonal IgG, 1/250 14
NPY Abcam, AB30914 Rabbit polyclonal IgG, 1/250 14
Isotype control Sigma, M5909 Mouse IgM 1/100 3
cFig. 1 Confocal fluorescent micrographs showing sagittal cryosec-
tions of 17 pcw human foetal olfactory system immunolabelled with
antibodies towards a, b TUJ (green), S100 (red) and SOX10
(magenta), c–e NCAM (red), TUJ (green), SOX10 (magenta) and
f–h GAP-43 (red), TUJ (green), SOX10 (magenta). Scale bar 40 lm,
dashed white lines indicate the surface of the olfactory bulb. a Precise
cross-section of an olfactory nerve showing numerous SOX10/S100?
OECs (white arrowheads) surrounding bundles of TUJ? olfactory
axons. b SOX10/S100? OECs (white arrowheads) are observed
throughout the olfactory nerve layer (ONL) and surrounding but rarely
within the glomerular layer (GL). c, f Olfactory receptor neurons
(white arrowheads) and their axons co-labelled with TUJ and NCAM
or GAP-43, respectively. d, g Cross-section of an olfactory nerve
showing co-labelling of TUJ? olfactory axons with NCAM and
GAP-43. Co-labelling with SOX10 is not observed (white arrows). e,
h Co-labelling of the ONL and GL with TUJ and NCAM or GAP-43,
respectively
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demonstrated SOX10 in the nucleus and S100 in the
nucleus and cytoplasm of OECs that were ensheathing
bundles of TUJ? axons (Fig. 1a). Long S100 positive
processes could be seen delineating axon fascicles in a
tube-like fashion where ONs were cut in a longitudinal
plane. The intensity of S100 labelling in the ONL sur-
rounding the OB was less than that observed in the ONs,
nonetheless, immunoreactivity in the ONL was still very
strong. SOX10 was observed in the nuclei of S100? OECs
throughout the ONL (Fig. 1b). In the outer ONL, longitu-
dinal S100? OEC processes generally followed the ori-
entation of the OB layers consistent with the morphology
of ONs entering the ONL, whilst in the inner ONL, OECs
appeared more heterogeneously orientated (Supplemental
Fig. 2a). At 17 pcw, S100/SOX10? OECs and their pro-
cesses could be seen surrounding the outside but rarely
within the developing TUJ? glomeruli (Fig. 1b). S100 was
not present within the olfactory epithelium (OE).
S100 Immunolabelling was also observed in chondro-
cytes in cartilage, weakly in the nucleus of cells in the
deeper OB layers, and weakly in the cytoplasm of cells
radiating outwards from the ventricle of the OB. SOX10
was also observed in the nucleus of duct cells in Bowman’s
glands, and diffusely in presumptive sustentacular cells in
the OE.
Immunolocalization of NCAM and GAP-43
Immunoreactivity to TUJ, NCAM and GAP-43 was intense
and tightly correlated in double labelling (TUJ/NCAM and
TUJ/GAP-43) along the entire olfactory pathway (Fig. 1c–
e and Supplemental Fig. 2b and Fig. 1f–h and Supple-
mental Fig. 2c, respectively). In the OE, the bipolar cell
bodies of ORNs could be clearly identified by intense
labelling with TUJ and slightly weaker to NCAM and Gap-
43 (Fig. 1c, f, respectively). The OE generally possessed a
pseudostratified columnar structure; however, in some
areas the epithelium appeared thickened with numerous
TUJ/GAP-43/NCAM? cells of presumptive neuronal ori-
gin (Supplemental Fig. 2 b3). Within the nasal stroma,
clusters of migrating TUJ/GAP-43/NCAM immunoreac-
tive neurons were also observed.
In the ONs, triple labelling of cross-sections with
SOX10/TUJ/NCAM or SOX10/TUJ/GAP43 showed tight
overlap between TUJ and NCAM, and TUJ and GAP-43,
but no clear overlap with SOX10 (Fig. 1d, g). Expression
of NCAM and GAP-43 by OECs could not be clearly
identified. The tight correlation of TUJ with NCAM and
GAP-43 suggests these antigens were only present on OSN
axons.
An intense band of NCAM and GAP-43 Immunola-
belling was observed surrounding the circumference of
the OB corresponding to the TUJ? ONL (Fig. 1e, h and
Supplemental Fig. 2 b, c). In 17 pcw samples,
immunolabelling by NCAM and GAP-43 could also be
observed in the developing TUJ? glomeruli (Fig. 1e, h,
respectively). Expression of NCAM and GAP-43
specifically on OECs in the ONL was difficult to con-
firm. Although tight overlap of NCAM and GAP-43 with
TUJ was observed in the ONL suggesting neuronal ori-
gin, these antigens could still have been present on OEC
processes in tight contact with axons not resolved by our
micrographs.
TUJ, NCAM and Gap-43 immunoreactivity was also
seen in small nerves surrounding arterioles and in facial
peripheral nerves. Weak GAP-43 labelling was also
observed in the meninges covering the brain (Supplemental
Fig. 2c1). Occasionally, a layer of GAP-43 ?/TUJ-
immunoreactivity was observed underneath the OE (Sup-
plemental Fig. 2d). Immunolabelling of adjacent sections
showed this area was not reactive for S100, P75NTR, PSA-
NCAM, nestin, NCAM, NPY or GFAP.
Immunolocalization of PSA-NCAM
PSA-NCAM labelling varied between the different foetal
samples. In the 12 pcw foetuses PSA-NCAM labelled both
intracranial and lamina propria ONs. Occasional PSA-
NCAM? ORNs were observed in the OE (Fig. 2a). PSA-
NCAM immunoreactivity in the ONs possessed an axonal-
like morphology that closely co-labelled with GAP-43 and
was surrounded by S100 (Fig. 2b, c). This suggests the
source of the PSA-NCAM was neuronal. Immunolabelling
in the ONs was variable with some nerve bundles moderate
to strongly immunoreactive and others very weakly
immunoreactive. In some tissue sections individual nerve
bundles could be followed from the OB to the OE. We
observed entire bundles that were either very strong or not
cFig. 2 Confocal fluorescent micrographs showing sagittal cryosec-
tions of a–d 12 pcw and e–h 17 pcw human foetal olfactory system
immunolabelled with antibodies towards a–d PSA-NCAM (green)
and a, b, d S100 (red) or c GAP-43 (red), e–f O4 (green) and S100
(red), g, h vimentin (red) and S100 (green). All scale bars 40 lm. d,
f Asterisk shows olfactory nerves merging with the olfactory nerve
layer (ONL). a Olfactory epithelium showing PSA-NCAM immuno-
labelled olfactory receptor neurons and olfactory axons (white
arrowheads). b Bundles of PSA-NCAM? axons (white arrowheads)
are ensheathed by S100? OECs (blue arrowheads). c PSA-NCAM
immunoreactivity in the olfactory nerves co-labels closely with GAP-
43. d PSA-NCAM immunoreactivity in the ONL. e Strong O4
immunoreactivity overlapped with S100? OECs in the olfactory
nerves but not in the ONL (f), except where ONs asterisk merged with
the ONL. g, h Co-labelling of vimentin with S100? OECs (yellow
arrowheads) is observed in g a cross-section of an olfactory nerve and
in h the olfactory nerve layer. Olfactory nerve perineurial cells (white
arrowheads) express vimentin but not S100. Blue arrowheads show
vimentin? S100- cells within the ONL and glomerular (GL)
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immunoreactive at all along the entire length of the nerve
(Supplemental Fig. 3a). PSA-NCAM labelling in the ONL
was variable and heterogeneous. Often it was either absent
or appeared as very weak to moderately immunoreactive
flecks. In the outer ONL long immunoreactive fibres were
observed where PSA-NCAM? nerve bundles entered the
OB (Fig. 2d). PSA-NCAM immunolabelling was very
similar between all the 12 pcw samples and the 19 pcw
cryosectioned samples; however, the 17 pcw sample had no
immunolabelling in the ONL and very rarely weak label-
ling in the ONs.
Immunolocalization of O4
The majority of O4 immunolabelling was concentrated in
the olfactory nerves; however, some background fluores-
cent speckles were occasionally seen deposited across the
tissue sections. Omitting Triton-X100 from all buffers and
antibody diluents did not prevent this.
We concluded that the decalcification, freezing and
cryosectioning process could be responsible for dispersion
of the O4 antigen. Despite the background speckles, it was
possible to identify consistent immunolabelling in the
olfactory nerves of all cryosectioned foetal samples where
this immunolabelling was intense and clearly different
from the background (Fig. 2e and Supplemental Fig. 3b).
This same intense labelling was not observed in the ONL
except where ONs merged with the bulb surface (Fig. 2f).
O4 immunolabelling was not observed in background (no
primary) or IgM isotype controls (Supplemental Fig. 3b1).
It was not possible to isolate the origin of O4 to OECs or
olfactory axons.
Immunolocalization of Vimentin
Vimentin was intensely expressed in a wide range of cells
within the olfactory system, in nervous tissue and in
meninges (Supplemental Fig. 3c). Cross-section of the
ONs showed co-labelling with S100? positive OECs
(Fig. 2g). Vimentin also labelled connective tissue and
olfactory nerve perineurial cells surrounding the outside of
OEC-axon units. Vimentin immunoreactivity was observed
in cells in the basal region of the OE (Supplemental
Fig. 3c). Strong vimentin expression was observed
throughout the OB. In the inner and outer ONL, vimentin
appeared to co-label with S100? OECs; however, S100-
vimentin? cells were also observed, especially within the
developing glomerular layer (Fig. 2h). Vimentin? cells
with weakly S100? nuclei radiated outward from the bulb
ventricle projecting from the deeper layers towards the
more superficial layers in a similar manner to nestin
(Supplemental Fig. 3c, d).
Immunolocalization of P75NTR, S100, and SOX10
Along the entire olfactory pathway P75NTR? cells delin-
eated the outside of olfactory nerves (Fig. 3a–c). In trans-
verse sections of ONs, P75NTR? cells enwrapped bundles
of S100/SOX10? OEC-axon units (Fig. 3b1). Fine
P75NTR? processes were also observed between the OEC-
axon units, but not within (Fig. 3b2–4 white arrows). In
z-stack confocal micrographs of precise ON cross-sections,
S100 and P75NTR immunoreactivity appeared to occupy
mutually exclusive areas with P75NTR solely on processes
of cells surrounding OECs, presumptive perineurial olfac-
tory nerve fibroblasts (ONFs), but not expressed by OECs
themselves (Fig. 3c). Rarely, individual fusiform P75NTR/
SOX10/S100? cells were observed free in the nasal
stroma. No P75NTR labelling was observed in the OE.
Small blood vessels were often observed within the
nasal mucosa and ONL surrounded by intensely P75NTR?
cells (Fig. 3a1, e, Supplemental Fig. 4a). P75NTR/SOX10/
S100? presumptive Schwann cells were often present in
peripheral nerve bundles alongside these vessels (Supple-
mental Fig. 4a). Moderate to weak P75NTR immunoreac-
tivity was also present in numerous S100- cells dispersed
within the nasal stroma (Fig. 3a1). These cells were more
numerous intracranially surrounding ONs, situated along
the intracranial surface of cribriform plate (Supplemental
Fig. 4b) and within nerve foramen within the cribriform
plate. P75NTR also intensely labelled cells in the meninges
surrounding the brain and OB (Fig. 3a1).
At the bulb surface, P75NTR immunoreactivity was
observed in cells surrounding S100? OECs in ONs as they
entered the outer ONL. Long P75NTR positive streaks could
be observed following the orientation of the OB layers on
cFig. 3 Fluorescent micrographs of sagittal cryosections from 17 pcw
human foetal olfactory system immunolabelled with antibodies
towards P75NTR (green), S100 (red), SOX10 (magenta), and DAPI
nuclear stain (blue). a Axioscan micrograph montages of the olfactory
bulb (OB) and olfactory nerves (ON, asterisk). Scale bar 500 lm.
S100 labels the entire olfactory nerve layer (ONL) and ONs, whereas
P75NTR surrounds the outside of the OB and ONs. P75NTR labelling
was also observed surrounding blood vessels (blue arrowhead); on
cells within the nasal stroma (white arrowheads) and intensely
expressed in meningeal tissue (yellow arrowhead). b Cross-section of
olfactory nerves showing P75NTR? processes (white arrows) sur-
rounding S100? OECs. b1 Scale bar 100 lm. b2–4 Scale bar 20 lm,
shows magnified images of area within white box in b1. c2–7 Serial
optical sections through a 13 lm z-stack (c1) showing DAPI labelled
nuclei and P75NTR? processes of perineurial cells (white arrows)
surrounding S100? OECs within a cross-section of an olfactory nerve
(asterisk). Scale bar 20 lm. d1–3 In the outer ONL, P75NTR is
expressed on cells (white arrowheads) surrounding ONs as they enter
the ONL, but not on SOX10/S100? OECs. Dashed white lines show
rough boundary of ONL, scale bar 20 lm. e P75NTR? cells surround
presumptive arterioles in the ONL, scale bar 20 lm
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the surface of the OB and in the outer ONL, but rarely in
the inner ONL (Fig. 3d). Where P75NTR was observed
within the inner ONL, this generally seemed to be asso-
ciated with the presence of blood vessels (Fig. 3e). Triple
immunolabelling demonstrated that S100/SOX10 and
P75NTR occupied mutually exclusive areas suggesting
expression was not on OECs.
Immunolocalization of GFAP and P75NTR
Anti-GFAP monoclonal and polyclonal antibodies resulted
in differing patterns of immunolabelling. Monoclonal
GFAP strongly labelled cells with an astrocyte morphology
in specific areas of the foetal brain. However, immunore-
activity was not observed in any sections of the OB, ONs,
lamina propria or OE, in any of the cryosectioned samples.
Neither was immunoreactivity observed in sagittal sections
of the developing eye, optic and oculomotor nerve.
Immunoreactivity to the polyclonal GFAP in the brain was
more widespread than the monoclonal GFAP. Additional
areas of the forebrain were moderately immunoreactive.
The optic nerve, oculomotor and facial nerves were
strongly immunoreactive. In paraffin sections treated with
antigen retrieval, strong GFAP immunoreactivity was also
observed in the dura mater.
Generally polyclonal GFAP expression within the ONL
was sparse (Fig. 4a, b). Occasionally elongated cells were
visible orientated parallel to the OB layers or extending into
the glomerular layer (Fig. 4a2ii, b, c white arrowheads). The
frequency of these cells was variable and in some tissue
sections immunolabelled cells were rarely observed. Co-la-
belling of GFAP with P75NTR in the ONL was not apparent.
Occasionally, weakly immunoreactive presumptive astro-
cytes were observed heterogeneously orientated within the
developing glomerular (Fig. 4b, c, blue arrowheads). Many
weakly GFAP? presumptive astrocytes were also visible in
the deeper layers of the bulb, the majority of which were
orientated parallel to the olfactory bulb layers, with some
projecting perpendicular towards the developing glomerular
layer (Fig. 4a1, c yellow arrowheads).
In general, polyclonal GFAP immunoreactivity was
absent from the ONs apart from occasional sporadic
immunoreactive streaks within the nerve bundles (Fig. 4-
a2ii, d blue arrows). GFAP immunolabelling did not appear
to co-label with P75NTR cells surrounding the ONs
(Fig. 4d). Occasionally, strong GFAP immunoreactivity
was observed throughout small nerve bundles (Fig. 4a
white arrows, f). The pattern of GFAP/P75NTR co-labelling
in these nerves was comparable to that observed in
peripheral facial nerves (Fig. 4e) and those surrounding
blood vessels suggesting these nerve bundles may not have
been olfactory in origin. Similar GFAP and P75NTR co-
labelling was not observed in nerves that were obviously
olfactory in origin i.e. large nerve bundles clearly entering
the olfactory bulb (Fig. 4a2i).
Immunolocalization of nestin
In precise cross-sections of ONs, nestin immunoreactivity
was not observed in S100? OECs (Fig. 5a). In a similar
manner to P75NTR immunolabelling (Fig. 5d), nestin?
cells were occasionally observed in-between and sur-
rounding the outside of bundles of S100? OEC-axon units
(Fig. 5a, b, white arrows). Nestin immunoreactivity was
also often present in the lamina propria and OE, but not co-
labelling with S100? OECs (Fig. 5c). Nestin immunore-
activity was most obvious within the OB. Numerous
intensely labelled cells radiated from the bulb centre
towards the periphery. Some co-labelled with moderate to
weak nuclear and cytoplasmic S100 (Supplemental
Fig. 3d). These cells reduced in numbers towards the
superficial layers of the OB; in the ONL comparatively few
nestin immunoreactive cells were observed. These sporadic
cells spanned both the inner and outer ONLs and were
heterogeneously orientated with some following the
direction of the OB layers. Co-labelling with S100/SOX10
OECs in the ONL was not obvious (Fig. 5e, f). Often
S100- nestin? cells were present around blood vessels,
around the outside of nerve bundles entering the ONL, and
were common in the glomerular layer (Fig. 5e, f, Supple-
mental Fig. 3d). Nestin immunoreactivity was intense in
the muscles of the eye but was not observed co-labelling
with S100? oculomotor nerves.
cFig. 4 Axioscan fluorescent montages (a) and confocal fluorescent
micrographs (b–f) of GFAP (red), P75NTR (green) and SOX10
(magenta) immunoreactivity in sagittal cryosections of a–d 17 pcw
and f 12 pcw human foetal olfactory system. Scale bars a1, a2
500 lm, a2i 200 lm, a2ii 100 lm, b–e 40 lm. f 20 lm. Dashed
white lines roughly denote inner and outer boundaries of the olfactory
nerve layer ONL, olfactory bulb OB, olfactory epithelium OE,
glomerular layer GL, olfactory nerves ON asterisk. Boxes in a2 show
position of magnified areas in a2i and a2ii. a GFAP immunoreactivity
in the ONL and ONs is sparse. Yellow arrowhead a1 shows GFAP?
astrocytes, a2i shows the majority of ONs asterisks do not express
significant GFAP, white arrowhead a2ii shows GFAP? cells in ONL,
blue arrows show sporadic GFAP in olfactory nerves asterisk. b,
c GFAP in the ONL and GL, white and blue arrowheads show
GFAP? cells in ONL and glomerular layer, respectively. Yellow
arrowheads show GFAP? presumptive astrocytes in the deeper
layers of the OB. d Sporadic GFAP in olfactory nerves which are
surrounded by P75NTR? perineurial cells. Co-labelling of GFAP &
P75NTR is not observed. Pattern of GFAP and P75NTR co-labelling in
peripheral facial nerves e is similar to that seen in occasional small
nerve bundles in nasal stroma f and a2ii white arrow
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Discussion
The immunocytochemical characterisation of OECs in the
olfactory system of animal models such as rats and dogs
has enhanced our understanding of OEC physiology and
established a range of antigenic markers that can be used to
identify OECs in experimental cultures. Identification of
surface markers such as P75NTR has also enabled the
development of important purification techniques to
enhance culture yields and eliminate unwanted cell types.
In contrast, limited information is available regarding the
antigenic characteristics of OECs in situ in the adult and
developing human olfactory bulb and olfactory nerves.
Studies in various animal models have shown slight but
important differences in the characteristics of OECs
between species. Demonstrating the identity and purity of
cell transplants is a prerequisite to gaining authorisation for
clinical trials of advanced therapeutic medicinal products.
Thus, a thorough characterisation of human OECs in situ
would be highly beneficial for the clinical development of
OEC transplants. To address this, we investigated the
in situ expression of common rodent OEC markers in the
developing 11-19 pcw human foetal olfactory system. We
assessed immunoreactivity to S100, P75NTR, PSA-NCAM,
Gap-43, vimentin, nestin, NPY, GFAP, and O4, and to a
lesser-known marker for OECs: SOX10.
Our results indicate that the antigenic properties of
OECs in the developing human have many similarities but
also some important differences with rodent OECs in situ.
Franceschini and Barnett (1996) provide a detailed
description of the antigenic characteristics of the devel-
oping and postnatal rat olfactory system (Franceschini and
Barnett 1996). From E14-P0, the olfactory nerves were
described as consistently PSA-NCAM? on the inside
Fig. 5 Confocal fluorescent micrographs showing a–c, e, f nestin
(green) and d P75NTR (green), a–f S100 (red) immunoreactivity in
sagittal cryosections of 17 pcw human foetal olfactory system. Scale
bars 40 lm. a White arrowheads show nestin immunoreactivity
surrounding the outside of S100? OECs in cross-sections of olfactory
nerves (ON). b Nestin immunoreactivity surrounding ONs and
between OEC-axon units (white arrowheads) in longitudinal sections
of ONs appears similar to P75NTR immunoreactivity d in adjacent
tissue sections. c Nestin immunoreactivity in the olfactory epithelium
(OE) and lamina propria (LP). e, f White boxes show magnified areas
of nestin? S100- cells (white arrows) in the ONL. e also shows
nestin? cells around a blood vessel asterisk in the ONL
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surrounded by a thin filamentous P75NTR? outer layer. At
the ventral surface of the OB, PSA-NCAM expressing cells
extended through openings in a P75NTR? layer that
wrapped around the PSA-NCAM? tissue. PSA-NCAM
immunoreactivity was restricted to the outer ONL until
birth when it was also detected at the ONL/GL boundary.
This configuration of an external P75NTR layer surrounding
a PSA-NCAM? layer was observed along the entire
olfactory pathway. They concluded that the PSA-NCAM?
tissue represented astrocyte-like OECs enwrapped by the
P75NTR? Schwann-like OECs. An additional layer of
P75NTR immunoreactivity covering the OB and entire
cortex was also observed and identified as meningeal tis-
sue. The migratory mass and olfactory axons extending
from the OE to the OB consistently labelled with NCAM,
vimentin and GAP-43 throughout development.
Our results showed some similarities with the configu-
rations of immunoreactivity described by Franceschini and
Barnett (1996). We observed consistent immunolabelling
with vimentin, S100, NCAM and GAP-43 along the entire
length of the ONs from the OE to the OB in our human
foetal samples. Furthermore, we also observed P75NTR in a
meningeal layer covering the OB, and in similar configu-
rations with PSA-NCAM immunolabelling. Consecutive
double-labelled sections revealed that PSA-NCAM? tissue
occupied areas surrounded by P75NTR? tissue in the ONs,
similar to that described by Franceschini and Barnett.
However, our results suggest a different cellular origin of
these two antigens in the developing human foetus from
that proposed by Franceschini and Barnett. Our high
magnification confocal fluorescent micrographs of the
olfactory nerves revealed three layers: S100- vimentin?
P75NTR? ONFs surrounding S100?, SOX10? and
vimentin? OECs which ensheathed NCAM, GAP-43, TUJ
and PSA-NCAM? bundles of ORNs axons.
We identified OECs by robust S100 and SOX10
immunolabelling that was consistently observed in cells
with the morphology of OECs that tightly ensheathed
TUJ? ORN axons in olfactory nerves, at all foetal ages
studied. S100/SOX10 expression in OECs was consistent
along the entire olfactory pathway and throughout the ONL
and was thus used where possible in triple antibody
labelled sections as a marker for OECs. We also confirmed
NCAM and GAP-43 as markers of ORN axons and not
OECs in olfactory nerves by co-labelling with TUJ (ORNs
axons) and SOX10 (OECs). Our results were consistent
with previous studies showing NCAM and GAP-43 in
ORN axons in human and mouse (Chuah and Au 1992; Au
et al. 2002; Iwema and Schwob 2003; Maresh et al. 2008).
Co-labelling with these markers revealed that PSA-NCAM
was present in ORN axons but not obviously in OECs. It is
possible that PSA-NCAM was present on OEC surfaces in
contact with ORN axons but this was not distinguishable
by fluorescence microscopy. Nevertheless, the pattern of
PSA-NCAM immunoreactivity we observed was consistent
with previous reports that only subpopulations of immature
ORNs express this antigen (Miragall and Dermietzel 1992).
Our most significant finding was that human OECs do
not appear to express P75NTR but perineural ONFs sur-
rounding OECs in olfactory nerve fascicles do strongly
express P75NTR. This was consistent among all the samples
analysed and throughout the olfactory system in both the
ONs and outer ONL. Expression of P75NTR by ONFs and
not OECs was most obvious in precise cross-sections and
z-stack confocal images of olfactory nerves. Co-labelling
with S100 and SOX10 demonstrated that P75NTR was on
cells surrounding OECs and did not appear to be on OECs
themselves. Without co-labelling with S100, the similar
distribution and morphology of P75NTR immunolabelling
in the olfactory nerves could be mistaken for labelling in
OECs. These results are similar to those found in adult
canine, guinea pig and cat, but in contrast to rat and murine
OECs (Gong et al. 1994; Franceschini and Barnett 1996;
Au et al. 2002; Au and Roskams 2003; Bock et al. 2007;
Smithson and Kawaja 2009). These results are also in
contrast with Liu et al. (2010) who observed substantial
P75NTR immunoreactivity in the ONL and surrounding
glomeruli in the olfactory bulb in 20 pcw human foetuses
(Liu et al. 2010). Differences between our study and Liu
et al. could be due to differing antibodies or foetal sample
age. Strong immunostaining in peripheral nerves in control
tissue sections taken from the same foetal samples, and in
the meningeal tissue (which is well reported) provides
confidence that the P75NTR antibody used in this study was
effective.
Electron micrograph studies have shown the configura-
tion of OEC ensheathment of olfactory axons and their
compartmentalisation into fascicles by basal lamina and
ONFs differs among species (Herrera et al. 2005; Kawaja
et al. 2009; Smithson and Kawaja 2009). In rodents, spaces
between OEC-axon units are packed with collagen fibres
and only a single loose layer of ONFs surrounds the outside
of ONs (Field et al. 2003). In larger mammals such as cats
and non-human primates Macaca fascicularis, each OEC-
axon unit within a larger fascicle is separated by collagen
fibres and a thin single cell layer endoneurium-like
fibroblastic process lacking a basal lamina (Herrera et al.
2005). Multiple fascicles are then surrounded by a second
layer of perineurial ONFs. Our results suggest the config-
uration in humans is similar to Macaca fascicularis. The
P75NTR? layers we observed surrounding the S100/
SOX10? OEC-axon units and fascicles are these endo-
neurial and perineurial ONFs. Smithson et al. (2009) and
Bock et al. (2007) reported a similar configuration of
P75NTR? cells surrounding olfactory nerves in adult guinea
pigs, cats and dogs and concluded these cells were ONFs.
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They did not observe P75NTR in OECs in these species
(Bock et al. 2007; Smithson and Kawaja 2009).
Our tissue sections of the foetal olfactory system often
contained nerves of peripheral origin coursing through the
nasal mucosa and alongside blood vessels in both the
peripheral and intracranial compartments of the olfactory
system. These small vessels were present within the outer
and inner ONL and along the surface of the olfactory bulb.
Similar to olfactory nerves we observed P75NTR immuno-
labelling in perineurial fibroblasts surrounding peripheral
nerves; however, in contrast to OECs, Schwann cells in
these nerves also strongly expressed P75NTR determined by
clear overlap with S100 immunoreactivity. Schwann cells
also expressed significantly more GFAP compared to
OECs. Similar to that described in the developing rodent
olfactory system, GFAP expression in OECs in the olfac-
tory nerves and ONL was very sparse whilst in peripheral
nerves, GFAP was intense and abundant throughout the
entire nerve bundle. These data show clear differences in
the phenotype of Schwann cells and OECs during the
developmental ages studied.
The finding that P75NTR is expressed by Schwann cells
and ONFs but not by OECs in situ has implications for
developing techniques to purify, identify and culture
human OECs. Traditional methods developed in rodents
whereby OECs are isolated by P75NTR immunopanning the
initial cell suspension would result in a culture that did not
contain OECs, only Schwann cells and ONFs. Alterna-
tively, P75NTR immunopanning after a period in culture
would allow time for OECs to upregulate P75NTR, but
would also isolate Schwann cells and presumably ONFs.
Using both these protocols sequentially to first remove
Schwann cells and ONFs, and then after a culture period to
isolate OECs could provide highly pure OEC cultures
similar to protocols described for canine OECs (Bock et al.
2007).
Transplants of OECs generated from the digestion of
whole human foetal olfactory bulbs are already being used
to treat hundreds of patients for various ailments including
SCI, stroke, cerebral palsy and neurodegenerative diseases
such as ALS (Huang et al. 2006, 2009; Chen et al.
2012, 2013, 2014; Xi et al. 2013). The transplanted cells in
these studies have been described as OECs and charac-
terised using antibodies towards P75NTR. No selective
purification methods have been described to isolate OECs
from other cells of the olfactory bulb indicating these
cultures are likely to contain a wide range of cells and not
just OECs. Liu et al. (2010) characterised human foetal OB
cultures generated using similar methods and found them
to contain just 23 % P75NTR? cells. Other cells in the
cultures were GFAP?, S100? and nestin?, possibly neu-
ral stem and precursor cells, reactive astrocytes or micro-
glia (Liu et al. 2010). Another report by Guest et al. (2006)
found similar cultures described as OECs contained nestin
and GFAP but no S100 and were morphologically remi-
niscent of human neurosphere cultures; the transplants
were not clearly OECs (Guest et al. 2006). Outcomes from
these human foetal OEC clinical studies have been con-
troversial. The ability to correctly identify and purify
human OECs is vital to understanding and developing
effective OEC therapies. We did not observed nestin in
OECs in the ONL of our foetal OB cryosections however,
many other cells that were not OECs in the glomerular and
deeper OB layers did express nestin, suggesting this marker
is not useful for identifying human OECs generated from
OB tissue.
SOX10 is a transcription factor required for the differ-
entiation of Schwann cells and for the development of
OECs in mice and chick (Kelsh 2006; Barraud et al. 2010;
Forni and Wray 2012; Pingault et al. 2013). Elucidating the
developmental pathways of OECs will be essential for
developing differentiation protocols to produce stem cell
derived human OECs. SOX10 has also been observed in
OECs in the mucosal olfactory nerves of a single 8-week
human foetus (Pingault et al. 2013). Our observations of
SOX10 confirm the presence of this key transcription factor
in OECs throughout the ONs and ONL in the 11–19 pcw
developing human.
Often, OECs are described as several different popula-
tions in vivo depending on their expression of various
markers. Franceschini and Barnett (1996) described two
OEC populations in rodent: astrocyte-like expressing PSA-
NCAM and fibrous GFAP, and Schwann-like expressing
P75NTR with diffuse GFAP (Franceschini and Barnett
1996). In the olfactory bulb of mice, Au et al. (2002)
identified P75NTR- S100? NPY? OECs in the inner ONL
and P75NTR/PSA-NCAM? OECs in outer ONL (Au et al.
2002). Pixley (1992) also described Schwann-like (S100/
P75NTR/GFAP?) and astrocyte-like (GFAP? and S100/
P75NTR-) OECs in situ in the olfactory nerves of neonatal
rats. Intensely GFAP? astrocyte-like OECs occurred as
isolated cells within the ONs, orientated parallel with the
longitudinal axis of the nerve (Pixley 1992). We observed
one population of OECs within both the ONs and ONL of
the developing human olfactory system that expressed
S100, SOX10, vimentin and heterogeneously small
amounts of fibrous GFAP (Table 3). We were unable to
confirm S100 co-labelling in GFAP? OECs as both anti-
bodies were raised in rabbit and our anti-mouse GFAP only
detected GFAP in small populations of astrocytes in the
forebrain. The GFAP? OECs we observed were similar to
that described by Pixley (1992) occurring as isolated cells
orientated parallel with the nerve (Fig. 4d). These cells
may represent a second OEC population, the astrocyte-like
OECs. We also describe another cell type that we assumed
to be ONFs based on its anatomical morphology i.e.
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ensheathing S100? OECs and not TUJ ORN axons. This
cell type was S100- vimentin? GFAP- P75NTR?, some
of which also expressed nestin.
We did not observe any differences in the immunola-
belling characteristics of OECs between the ONs and ONL
other than O4, which labelled ONs but was absent in the
ONL. O4 was previously considered to be a surface marker
for rodent OECs and has been used by several groups to
enrich OEC cultures using FACs (Franceschini and Barnett
1996). O4 immunoreactivity on rodent OECs in vivo was
initially described by immunofluorescence. Later studies
utilising immunoelectron microscopy revealed this antigen
was actually present on ORN axons and not OECs
(Wewetzer et al. 2005). This study concluded that O4
observed on OECs in vitro was from phagocytosed axonal
fragments and not endogenous expression; this has been
disputed and remains unresolved. We were unable to
identify the origin of O4 immunoreactivity in the human
foetal olfactory system and thus, this requires further
investigation by immunoelectron microscopy. We were
also unable to identify a NPY? OEC population equivalent
to that described by Ubink in the ONL of embryonic rats
suggesting this neurotrophic factor may not be involved in
human olfactory development at the foetal ages studied
(Ubink and Ho¨kfelt 2000).
Antigenic properties of ONFs
The identification of P75NTR? S100- ONFs in this study
raises a number of important questions: Do we see similar
P75NTR immunoreactivity in adult human ONFs, alluded to
by Holbrook et al. 2016? What are the morphological and
antigenic characteristics of these cells in culture? Do they
continue to express P75NTR in vitro and if so, what pro-
portion of these cells persist in OEC cultures that are tra-
ditionally characterised based on P75NTR purity. In rodent
OEC cultures, ONFs are normally characterised by positive
labelling for fibronectin, Thy-1, Smooth muscle actin and
negative for P75NTR (Li et al. 2008; Toft et al. 2013). This
is similar to the phenotype of endoneurial fibroblasts found
in the peripheral nerves of mice that along with Schwann
cells differentiate from a non-neuronal restricted progenitor
cell originating from the neural crest (Joseph et al. 2004).
This non-neuronal restricted progenitor cell is charac-
terised by expression of P75NTR, S100b and desert
hedgehog. Differentiation along the fibroblast lineage
results in the loss of P75NTR and desert hedgehog and
expression of Thy-1. Human ONFs clearly differ anti-
genically from rodent ONFs and peripheral nerve endo-
neurial fibroblasts. Dissecting the function of P75NTR
expression is difficult as this pan-neurotrophin receptor and
NOGO-66 coreceptor mediates a wide range of extremely
complex signals, many of which are still being deciphered.
P75NTR is expressed in neurons and glial cells as well as
many mature non-neuronal cells such as endothelial cells
and perivascular fibroblasts. It is also expressed in various
types of mesenchymal cells and embryonic and adult stem
cells. Among many functions, P75NTR mediates cell death
and survival, proliferation, differentiation, migration, and
has essential roles in controlling the development of the
nervous system including neuronal survival, neurite out-
growth and retraction, and myelination (Rabizadeh and
Bredesen 2003). Schwann cell P75NTR is vital for pro-
moting peripheral nerve regeneration after injury (Zhou
and Li 2007). P75NTR is also involved in controlling
pluripotency and modulating cell-fate decisions in stem
cells (Tomellini et al. 2014). The significance of P75NTR in
human ONFs remains to be investigated.
As well as P75NTR, our results indicate that a propor-
tion of human ONFs also express nestin. Nestin is a
cytoskeletal intermediate filament protein associated with
an immature phenotype expressed abundantly in progen-
itor and multipotent stem cells and in various tissues
during development, particularly in the nervous system
(Michalczyk and Ziman 2005). During differentiation
nestin is normally replaced by cell type specific inter-
mediate filament proteins but can be re-expressed tran-
siently during tissue regeneration and wound healing. The
expression of nestin in human ONFs is not entirely
unexpected as nestin has been previously reported in
myofibroblasts in various different tissues (Kishaba et al.
2010), in fibroblasts cultured from human olfactory
mucosa biopsies (Wu et al. 2013), and in a sub-population
of endoneurial fibroblast-like cells in rodent and human
peripheral nerves (Richard et al. 2014). Richard et al.
(2014) reported that after peripheral nerve injury in
rodents, the number of nestin expressing endoneurial
fibroblast-like cells significantly increased leading them to
speculate that these cells may have progenitor-like prop-
erties. Similarly, the presence of nestin in human ONFs
could indicate progenitor-like properties. It is currently
unknown to what extent human ONFs are needed in OEC
transplants to achieve therapeutic outcomes. Previous
studies in rodents have suggested that ONFs are a crucial
component of therapeutic OEC transplants facilitating the
formation of OEC bridges through which axons can
regenerate across growth inhibitory CNS tissue. Electron
microscopy studies have shown that after transplantation
into spinal cord lesions, ONFs wrap around OEC channels
forming a sheath similar to their physiology in situ (Li
et al. 1998). During culture, ONFs also contribute to the
production of a gel-like endogenous matrix that provides
a useful vehicle for transplanting OECs to the injury site.
Thus, although P75NTR immunopanning as described may
allow the generation of human OECs cultures free from
Schwann cells, further surface markers will be needed to
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isolate ONFs from Schwann cells to investigate their role
in the regenerative properties of OEC transplants.
In summary, we show that human foetal OECs possess
both similarities and important differences with rodent
OECs in situ. Most significant of these findings is that
ONFs and not OECs express P75NTR in the developing
foetus. However, this antigen could still be used in proto-
cols to remove P75NTR? Schwann cells and fibroblasts and
eventually isolate OECs after P75NTR upregulation in vitro,
to generate purified cultures from foetal tissue. We define
OECs throughout the 11–19 pcw human olfactory system
as S100/vimentin/SOX10? with very small amounts of
GFAP. Expression of O4 on OECs and not ORN axons
in situ remains to be proven and presently it is not a robust
surface marker for OEC purification. PSA-NCAM is also
not a suitable surface marker for OEC purification owing to
its heterogeneous expression on ORN axons and lack of
reliable labelling of OECs in the human foetus. Our results
highlight the importance of corroborating cell markers
when translating cell therapies from animal models to the
clinic.
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